Year: 2018

Veryan News

Otsuka Medical Devices Acquires Veryan

Dublin, Ireland, 14 December, 2018.  Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), a 100% subsidiary of Otsuka Holdings Co., Ltd., and Veryan Medical Ltd. (“Veryan”) have announced the completion of the acquisition of Veryan by Otsuka Medical Devices through its UK subsidiary Otsuka Medical Devices UK Ltd. Veryan’s BioMimics 3D peripheral vascular stent received …

Otsuka Medical Devices Acquires Veryan Read More »

Atlantic Innovo News

Atlantic Therapeutics Secures FDA Approval

FDA Grants DeNovo Clearance to Atlantic Therapeutics for INNOVO® Therapy Device to Treat Stress Urinary Incontinence. Galway, Ireland. 13 November 2018. Seroba’s portfolio company, Atlantic Therapeutics, a global manufacturer of innovative, garment-based pelvic floor muscle strengthening and nerve stimulation products, has announced that the U.S. Food and Drug Administration (FDA) has granted a DeNovo clearance …

Atlantic Therapeutics Secures FDA Approval Read More »

Quanta News

Quanta Wins Industrial Product Design 2018

Alcester, UK, 1 October 2018: Quanta Dialysis Technologies Ltd (“Quanta”), a medical device company pioneering innovative haemodialysis products for dialysis patients, is pleased to announce that it has won the “Industrial Product Design of the Year” award at the Plastics Industry Awards 2018. John E. Milad, Chief Executive Officer of Quanta, said: “I am delighted …

Quanta Wins Industrial Product Design 2018 Read More »

Endotronix News

Endotronix Raises $45M Series D Financing

Ireland and USA, 14 Sept 2018. Endotronix, Inc., a digital health, medtech company dedicated to advancing the treatment of heart failure, today announced the close of a Series D financing round totaling $45 million. The round was led by LSP, investing from its LSP Health Economics Fund 2, and included Aperture Venture Partners, BioVentures Investors, Lumira …

Endotronix Raises $45M Series D Financing Read More »

Labcyte News Logo

Labcyte Partners with GP-write in Large-Scale Genomic Testing

17 July, 2018, California, USA.   Labcyte Inc., today announced an agreement with the Center for Excellence in Engineering Biology (CEEB), an independent nonprofit that is managing initial planning and coordination of efforts for the Genome Project-write (GP-write). As part of the agreement, Labcyte will provide preferred pricing and in-kind support to researchers at qualified laboratories …

Labcyte Partners with GP-write in Large-Scale Genomic Testing Read More »

Pq Bypass

PQ Bypass Reports Positive 12-Month Results

28 June 2018.  Results from the DETOUR I Trial evaluating the PQ Bypass DETOUR System for percutaneous bypass showed promising 12-month durability for patients with extremely long blockages in the superficial femoral artery (SFA).  The data were presented as a late-breaking clinical trial session last week at the Society for Vascular Surgery (SVS) Vascular Annual …

PQ Bypass Reports Positive 12-Month Results Read More »

Quanta News

Quanta Successfully Completes Pilot Treatments in France

Alcester, UK, 25 April 2018.  Seroba’s investee company Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical device company providing innovative haemodialysis solutions, has announced that it has successfully completed a clinical pilot to treat patients in France. Building off its successful UK pilot, this is the first time Quanta’s personal haemodialysis system, SC+ …

Quanta Successfully Completes Pilot Treatments in France Read More »

T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19
Ireland

Scroll to Top